Cn / En

CM05607


CM05607

Key word胰腺癌, PDX, 体内药效,体外药效,免疫系统人源化,,

Model Information

Model IDCM05607
Cancer Type胰腺癌
Cell Subtype腺癌
Differentiation中分化
Collection SiteHead
Metastatic Site 
GradeIA
TNM stagingT1NxMx
IHC diagnosis免疫组化(M22-01538,蜡块2205902-c3)示:肿瘤细胞CAN5.2(+),CK5/6(少部弱+),CK7(+),CK8/18(+),CK19(+),CK20(-),F-cadherin (+),CDX2(-),DPC4(+),p40(-),p63(-),MUC1(+),MUC2(-),MUC5AC(+),MUC6(部分+),PP(胰岛+),S-100P(+),SMA(间质+),p16(+),p21(部分+),CD34(血管+),D2-40(间质+),CD44(部分+),β-catenin (
Pathology diagnosis

背景病理:PanIN :2-3级 腺泡导管化:(+)

慢性胰腺炎:(+)

IPMN:(+,胃型,分支胰管型,上皮高级别异型增生)

分级与分期:病理分级:中分化

病理诊断:(胰头)中分化导管腺癌,肿瘤最大径1.5cm

Clinical Treatment Records 

Model Data

Histopathological Images

 

Tumor growth curve

  

In vivo efficacy of SOCs

  
  
  
  

In vitro efficacy of SOCs